CTNM - Contineum Therapeutics Inc. - Ordinary Shares - Class A
IEX Last Trade
19.42
0.510 2.626%
Share volume: 43,782
Last Updated: Fri 30 Aug 2024 09:56:41 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.91
0.51
2.70%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.84%
1 Month
-8.02%
3 Months
29.93%
6 Months
26.56%
1 Year
26.56%
2 Year
26.56%
Key data
Stock price
$19.42
DAY RANGE
N/A - N/A
52 WEEK RANGE
$13.27 - $22.00
52 WEEK CHANGE
$0.27
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news